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1. Introduction
  Diabetes mellitus (DM), a chronic disease affecting 
millions of individuals worldwide, characterized by 
absolute or relative deficiencies in insulin secretion and/or 
insulin action associated with chronic hyperglycemia and 
disturbances of carbohydrate, lipid and protein metabolism. 
Based on the World Health Organization (WHO) report, the 
number of diabetic patients is expected to increase from 171 
million in year 2000 to 366 million or more by the year 2030 [1].
Hyperglycemia, due to uncontrolled glucose regulation is 
considered as the causal link between diabetes and diabetic 
complications. A number of studies emphasizes that 
alterations in glucose metabolism leads to hyperglycemia-
induced cell damage by four key metabolic pathways, 
viz., increased polyol pathway flux, increased glycation 
of proteins (enzymatic or nonenzymatic), increased 
hexosamine pathway flux and activation of protein kinase 
C (PKC) isoforms [2]. Among the above stated possibilities, 
glycosylation of proteins has been the prime subject 
of much interest. Glycoproteins, a carbohydrate linked 
protein macromolecules found in the cell surface, serves 
as the principal component of animal cells. Alterations in 
glycoprotein level leads to the pathogenesis of diabetes 
mellitus [3]. Many studies confirm the involvement of 
glycoprotein in diabetic complications [4]. With increasing 
severity of diabetes, there is a parallel rise in glycoprotein 
levels [5]. During diabetes, utilization of glucose by insulin 
independent pathways leads to the synthesis of glycoprotein 
which may be a predictor of angiopathic complications [6]. 
Objective: To investigate the protective role of Cardiospermum halicacabum (C. halicacabum) 
leaf extract on glycoprotein metabolism in streptozotocin (STZ)-induced diabetic rats. Methods: 
Diabetes was induced in male albino Wistar rats by intraperitonial administration of STZ. The 
C. halicacabum leaf extract (CHE) was administered orally to normal and STZ-diabetic rats for 
45 days. The effects of C.  halicacabum leaf extract (CHE) on plasma and tissue glycoproteins 
(hexose, hexosamine, fucose and sialic acid) were determined. Results: The levels of plasma 
and tissues glycoproteins containing hexose, hexosamine and fucose were significantly increased 
in STZ-induced diabetic rats. In addition, the level of sialic acid significantly increased in 
plasma and liver while decreased in kidney of STZ-induced diabetic rats. After administration 
of CHE to diabetic rats, the metabolic alteration of glycoprotein reverted towards normal levels. 
Conclusions: The present study indicates that the CHE possesses a protective effect on abnormal 
glycoprotein metabolism in addition to its antihyperglycemic activity. 
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An increase in the biosynthesis and or a decrease in the 
metabolism of glycoproteins attributed to the deposition of 
these materials in the basal membrane of pancreatic cells. 
In recent times, many traditionally important medicinal 
plants have been tested for their efficacy against impaired 
glycoprotein levels in diabetes [7,8].
  Plants used in traditional medicine to treat diabetes 
mellitus represent a valuable alternative for the control 
of this disease. C. halicacabum L. (CH) has been used 
in Chinese medicine for a long time in the treatment of 
rheumatism, lumbago, nervous diseases, as a demulcent in 
orchitis and in dropsy [9-11]. Various pharmacological actions 
of CH have been investigated in animal models [12]. The anti-
inflammatory activity of ethanolic extract against inhibits 
LPS induced COX-2, TNF-alpha and iNOS expression in 
RAW264.7 cells [13]. Experimental pharmacological studies 
have shown the analgesic and vasodepressant activities [14], 
antipyretic activity against yeast-induced pyrexia in rats [15],
antimalarial [16], antioxidant activity [17], suppressing 
the production of TNF- alpha and nitric oxide in human 
peripheral blood mononuclear cells [18, 19] and anti-ulcer 
activity against ethanol induced gastric ulcer in rats [20]. 
Our earlier study, reported that methanolic extract of
C. halicacabum possesses antihyperglycemic and antioxidants 
potential against STZ-induced diabetic rats [21, 22]. Hence, 
the current work to investigate the protective role of C. 
halicacabum leaf extract (CHE) on glycoproteins metabolism 
in STZ-induced diabetic rats. 
2. Materials and methods
2.1. Animals
  Male albino Wistar rats (weighing 180-200 g, 9 weeks old) 
were procured from the Central Animal House, Department 
of Experimental Medicine, Rajah Muthiah Medical College 
and Hospital, Annamalai University, and maintained in an 
airconditioned room [(25依1) 曟] with a 12 h light/12 h dark 
cycle. Feed and water were provided ad libitum. The study 
was conducted in accordance with the National Institute of 
Health Guide for the Care and Use of Laboratory Animals 
(NIH, 1985) and the experimental study was approved by the 
Ethical Committee of Rajah Muthiah Medical College and 
Hospital (Reg No.160/1999/CPCSEA), Annamalai University, 
Annamalainagar.
2.2. Chemicals
  Streptozotocin was obtained from Sigma-Aldrich Company 
(St. Louis, Missouri, USA). All other chemicals used were 
of analytical grade obtained from E. Merck, Mumbai and 
HIMEDIA, Mumbai, India.
2.3. Experimental induction of diabetes
  The animals were made diabetic by an intraperitoneal 
injection of streptozotocin (STZ, 40 mg/kg body weight, 
between 8:00 AM to 9:00 AM) in a freshly prepared citrate 
buffer (0.1M, pH 4.5) after an overnight fast. STZ injected 
animals were given 20% glucose solution for 24 h to prevent 
initial drug-induced hypoglycaemic mortality. The animals 
exhibited massive glycosuria (determined by Benedict’s 
qualitative test, Benedict 1911) and hyperglycaemia within 
a few days. Diabetes was confirmed by measuring the 
fasting blood glucose concentration 96 h after induction[23]. 
Albino rats with a blood glucose level above 220 mg/dL were 
considered diabetic and were used in the experiment.
2.4. Plant material
  Leaves of C. halicacabum were collected from the local 
areas, Jeyankondam, Ariyalur district, Tamil Nadu, India. 
The plant was botanically identified and authenticated 
in the Department of Botany, Annamalai University, 
Annamalainagar, Chidambaram, Tamil Nadu, India and a 
voucher specimen was deposited at the herbarium of botany.
2.5. Preparation of plant extract
  The plant leaf was shade dried at room temperature [(32依
2) 曟] and the dried leaf was ground into fine powder using 
a pulverizer. The powered part was sieved and kept in deep 
freezer until use. 100 g of dry fine powder was suspended in 
300 mL of ethanol for 72 h. The extract was filtered using a 
muslin cloth and concentrated at [(40依5) 曟].
2.6. Experimental design
  The animals were randomly divided into five groups of 
six animals each. In our earlier study, the extract was 
suspended in 2% gum acacia vehicle solution and fed by 
intubation at three different doses such as 50, 100 and 200 
mg/kg body w.t. The dose of 200 mg exhibited maximum 
reduction of blood glucose when compared to the other two 
doses in STZ-induced diabetic rats [22]. The active dose of 
200 mg was used in this study. 
  Group I: Normal (2% gum acacia), Group II: Normal + CHE 
(200 mg/kg body wt.) in 2% gum acacia, Group III: Diabetic 
control rats, Group IV: Diabetic + CHE (200 mg/kg body wt.) 
in 2% gum acacia, Group V: Diabetic + glibenclamide (600 
毺g/kg body wt.) in 2% gum acacia. 
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  After 45 days, the animals were anaesthetized using 
ketamine (24 mg/kg/body weight, intramuscular injection), 
and sacrificed by cervical dislocation. Between 8:00 am 
and 9:00 am blood was collected in tubes with a mixture of 
potassium oxalate and sodium fluoride (1:3) to get plasma for 
various assays. Tissues (liver and kidney) were collected and 
stored at 4 曟 for the measurement of various parameters.
2.7. Biochemical estimations 
  Blood glucose was estimated by using the reagent kit 
method of Trinder [23]. Total hexoses, hexosamine, fucose 
and sialic acid were estimated by the methods of Niebes [24], 
Elson and Morgon [25], Dische and Shettles [26] and Welmer et 
al [27], respectively. 
2.8. Statistical analysis
  Values are given as means依S.D. for six rats in each group. 
Data were analyzed by one-way analysis of variance 
followed by Duncan’s Multiple Range Test (DMRT) using 
SPSS version 10 (SPSS, Chicago, IL). The limit of statistical 
significance was set at P≤ 0.05.
3. Results
  Table 1 shows the effect of the 45 day oral administration 
of CHE on blood glucose levels in normal and STZ-diabetic 
rats. Diabetic rats showed an elevated blood glucose level 
and administration of CHE and glibenclamide in diabetic 
rats showed a decreased blood glucose level.
  Table 2 represent the levels of total hexoses and 
hexosamines in the plasma and tissues (liver and kidney) 
of normal and diabetic rats. The diabetic rats had increased 
levels of total hexoses and hexosamines in the plasma and 
tissues and treatment with CHE and glibenclamide showed 
reversal of these parameters towards normal levels.  
  Tables 3 represent the levels of fucose and sialic acid in the 
plasma and tissues (liver and kidney) of normal and diabetic 
rats. The diabetic rats had increased levels of fucose and 
sialic acid (except kidney) in the plasma and tissues while 
Table  1
Effect of alcoholic leaf extract of C. halicacabum (CHE) on the glucose levels in the plasma of normal and STZ-diabetic rats.
Groups
Glucose (mg/dL)
0th day After 45 days
Normal control (2% gum acacia)   66.54依5.89  74.55依4.34a
Diabetic control 246.63依9.45   290.52依16.24b
Normal + CHE (200 mg/kg body wt.)   72.48依5.52   68.93依3.94a
Diabetes + CHE (200 mg/kg body wt.)  246.37依12.39 138.45依7.10e
Diabetes + glibenclamide (600 毺g/kg body wt.)  251.38依17.48   98.50依9.56f
Values are means 依 SD of 6 rats from each group, values not sharing a common superscript differ significantly at P< 0.05 (DMRT).
Table  2















Normal control (2% gum acacia) 102.27依6.89af 22.22依0.78a 20.05依1.11a 45.12依1.17a 8.11依1.94a 5.48依0.49af
Diabetic control 165.15依8.46b 41.04依1.101b 38.13依2.66b 65.34依3.53b 20.22依3.09b 14.22依1.26b
Normal + CHE (200 mg/kg body wt.)   99.24依7.83a 20.98依1.15a 18.18依1.07a 43.34依2.27a 7.45依1.76a 4.51依0.21a
Diabetes + CHE (200 mg/kg body wt.) 120.45依5.57e 28.03依1.73e 27.27依2.40e 51.78依1.82e 11.44依2.13d 6.20依0.56e
Diabetes + glibenclamide (600 毺g/kg body wt.) 109.00依6.51
f 24.24依2.14f 22.98依2.90f 47.89依2.02f 9.33依1.74ad 5.19依0.47f
Values are means 依 SD of 6 rats from each group, values not sharing a common superscript differ significantly at P< 0.05 (DMRT).
Table  3















Normal control (2% gum acacia)   8.75依0.81a 14.48依1.35a 11.67依1.08a 42.14依2.63a,f   8.18依0.69a 7.42依0.26a
Diabetic control 15.11依1.16b 27.16依2.46b 25.42依1.94b 67.14依2.02b 17.86依0.88b 2.90依0.16b
Normal + CHE (200 mg/kg body wt.)   7.82依0.60a 13.14依1.08a 10.83依0.68a 40.59依1.77a   7.14依0.67c 8.10依0.31c
Diabetes + CHE (200 mg/kg body wt.) 10.32依0.94d 17.08依1.54e 15.83依1.36e 50.35依2.38e 10.24依0.60f 6.07依0.27e
Diabetes + glibenclamide (600 毺g/kg body wt.)   8.91依0.81
a 15.83依1.24ae 12.36依0.89a 44.10依1.63f   9.05依0.54a 6.98依0.40f
Values are means 依 SD of 6 rats from each group, values not sharing a common superscript differ significantly at P< 0.05 (DMRT).
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treatment with CHE and glibenclamide showed reversal of 
these parameters towards normal levels. 
4. Discussion
  Streptozotocin selectively destroys the pancreatic insulin 
secreting 毬-cells, leaving less active cells and resulting 
in a diabetic state [28,29]. The fundamental mechanism 
underlying hyperglycaemia in diabetes mellitus involves 
the overproduction (excessive hepatic glycogenolysis and 
gluconeogenesis) and decreased utilization of glucose by the 
tissues [30], and studies have shown that the level of blood 
glucose was elevated in STZ-induced diabetic rats. Hence, 
in the present study, we observed an increased level of blood 
glucose. Oral administration of CHE resulted in a significant 
reduction in blood glucose. Flavonoids are one of the most 
numerous and widespread groups of phenolic compounds 
in higher plants [31]. Some of them, due to their phenolic 
structure are known to be involved in the healing process 
of free radical mediated diseases including diabetes [32].
The plant leaf possesses several flavonoids such as 
apigenin, pinitol and luteolin [33], which are reported as the 
antidiabetic principles. Apigenin, a component of CHE, was 
also isolated from flowers of Platycodon grandiflorum and 
found to possess an inhibitory effect on the aldose reductase 
enzyme [34]. This enzyme is known to play a key role in the 
polyol pathway, by catalyzing the reduction of the glucose to 
sorbitol, which under normal conditions cannot diffuse out of 
cell membranes. Because of the intracellular accumulation 
of sorbitol, the chronic complications (such as neuropathy, 
retinopathy and cataracts) of diabetes can occur. Apigenin 
and luteolin were shown to possess antihyperglycaemic [35, 
36], and antioxidant activity [36,37].
  Glycoproteins are carbohydrate l inked protein 
macromolecules found in the cell surface, which form 
the principle components of animal cells. They play an 
important role in membrane transport, cell differentiation and 
recognition, the adhesion of macromolecules to cell surface 
and the excretion and absorption of macromolecules [39].
Prolonged elevation of blood glucose in diabetes may 
result in structural and functional alterations of both 
circulating and membrane bound proteins [40]. Alterations 
in the diabetic state of the composition of the carbohydrate 
components of glycoproteins, especially serum glyloproteins 
and glycoproteins of the capillary basement membrane have 
been reported [41].
  Protein bound hexoses in the cell membrane provides 
hydrophobic areas, whereas protein bound hexosamine 
provides cationic charges on the cell membrane surface 
and make the membrane more polar. The elevated level of 
hexoses in diabetic rats may be associated with disturbances 
with carbohydrate metabolism. Treatment with CHE 
and glibenclamide in diabetic rats showed significantly 
decreased hexoses due to improved glycemic control. 
Hexosamines function as physiologic glucose sensors that 
serve as an adaptor in diverting excess calories toward 
storage as fat [42]. One pathway through which glucose is 
sensed subacutely is hexosamine synthesis. The amination 
of fructose-6-phosphate to glucosamine-6-phosphate 
is rate limiting and is catalysed by glutamine fructose-
6-phosphate aminotransferase (GFA) [43]. In accordance 
with previous report diabetic rats had elevated level of 
hexosamines, which could be due to, increased expression 
of GFA and increased plasma glucose. In our report, diabetic 
rats had elevated level of hexosamine in plasma and tissues 
when compared with normal rats. Diabetic rats treated with 
CHE and glibenclamide showed significantly decreased 
hexosamines in the plasma and tissues when compared to 
diabetic rats, which could be due to improved glycemic 
control.
  Sialic acid is the terminal residue of the oligosaccharide 
side chain of glycoproteins and widely occurs in the exposed 
positions of molecules like hormones, enzymes and also on 
tissues. Elevated levels of serum sialic acid are considered 
to be a good predictor of cardiovascular disease [44]. Diabetic 
rats had increased level of sialic acid in the plasma and 
tissues [45]. In our study, the level of sialic acid in plasma 
and tissues of diabetic control rats significantly elevated 
when compared to normal rats. The elevated level of sialic 
acid in diabetic rats might be due to either enhanced sialic 
acid synthesis or decreased sialidase activity. Sialic acid 
contributes to the negative charges on this membrane, 
thus possibly playing a role in the selective glomerular 
permeability to negative charged proteins [46]. It has been 
postulated that an increased activity of sialidase, an enzyme 
which catalyses the removal of sialic acid residues from 
sialoconjugates which might be responsible for the depletion 
of glomerular sialic acid [47]. Treatment with CHE and 
glibenclamide had significantly decreased sialic acid in the 
plasma and tissues of diabetic rats, which could be due to 
the regulation of sialidase activity by insulin, since insulin 
is a more likely mediator of sialic acid changes than any 
other alterations in plasma glucose levels [45].
  Fucose (6-deoxy-L-galactose) is a characteristic 
constituent of many glycoproteins], and is a mobile 
component of plasma glycoproteins of particular 
physiological and pathological significance. In our study, 
diabetic rats had elevated level of fucose, which could be 
due to elevated blood glucose level, which is in line with 
previous report [45]. Treatment with CHE and glibenclamide 
in diabetic rats had significantly decreased fucose levels, 
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which could be due to improved glycemic control.
  The biosynthesis of the carbohydrate moieties of 
glycoprotein forms the insulin independent pathways for 
the use of glucose 6-phosphate. But the deficiency of insulin 
during diabetes produces derangement of glycoprotein 
metabolism, resulting in the thickening of the basal membrane 
of pancreatic beta cells. In hyperglycemic state, the excess 
availability of glucose accelerates the synthesis of glucose 
basement membrane components i.e., glycoproteins [47].
Agents with antioxidant or free radical scavenging property 
may inhibit oxidative reactions associated with glycation. 
In this context, previous studies have shown that decrease 
in hyperglycemia could lead to a decrease in glycoprotein 
levels [45]. Administration of CHE to diabetic rats resulted in 
a significant reversal of all these changes to near normal.
  In conclusion, the decreased hyperglycemic state in CHE 
treated diabetic rats might have been responsible for the 
decrease of glycoproteins in plasma, liver and kidney. The 
observed effect of CHE on reversing the adverse effects of 
hyperglycemia provides an insight into the pathogenesis of 
diabetic complications, and may be used to advantage in 
therapeutic approaches.
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